SCHEMBL20614872

SCHEMBL20614872

O=C(CCCn1c(SCC(=O)NCC2CCCO2)nc2ccccc2c1=O)NCc1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 4/20 0.87
▸ LMNA P02545 1/20 0.87
▸ ALDH1A1 P00352 8/20 0.81
▸ HPGD P15428 2/20 0.81
▸ NPSR1 Q6W5P4 3/20 0.81
▸ HTT P42858 1/20 0.81
▸ USP2 O75604 2/20 0.76
▸ KMT2A Q03164 4/20 0.76
▸ MEN1 O00255 3/20 0.74
▸ KDM4E B2RXH2 2/20 0.73
▸ POLB P06746 1/20 0.73
▸ GAA P10253 1/20 0.73
▸ MAPT P10636 1/20 0.73
▸ ALPG P10696 1/20 0.73
▸ ALOX15 P16050 1/20 0.73
▸ ALOX12 P18054 1/20 0.73
▸ RECQL P46063 1/20 0.73
▸ L3MBTL1 Q9Y468 1/20 0.73
▸ PABPC1 P11940 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL647000 0.85 ALDH1A1 (1.00) SMN1; SMN2LMNAALDH1A1HPGDNPSR1
SCHEMBL3866653 0.78 ALDH1A1 (0.58) SMN1; SMN2LMNAALDH1A1HPGDNPSR1
SCHEMBL3868831 0.76 GAA (0.91) LMNAALDH1A1NPSR1HTTKDM4E
SCHEMBL12830660 0.71 KMT2A (0.81) SMN1; SMN2LMNAALDH1A1HTTUSP2
SCHEMBL28732507 0.71 IGSF11 (1.00) SMN1; SMN2LMNAALDH1A1HPGDKMT2A
SCHEMBL12870002 0.70 USP2 (0.70) SMN1; SMN2LMNAALDH1A1HPGDNPSR1
SCHEMBL12961753 0.70 HPGD (0.77) SMN1; SMN2LMNAALDH1A1HPGDNPSR1
SCHEMBL16896085 0.69 KMT2A (1.00) LMNAALDH1A1HPGDKMT2AMEN1
SCHEMBL2722164 0.68 POLB (0.82) LMNAALDH1A1HPGDNPSR1HTT
SCHEMBL28672670 0.68 HPGD (0.69) SMN1; SMN2ALDH1A1HPGDNPSR1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220204484-A1 CHEMICAL INHIBITION OF THE E3 LIGASE SUBUNIT FBXO7 CONFERS NEUROPROTECTION AND ANTI-INFLAMMATORY ACTIVITY BY STABILIZING MITOCHONDRIA UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2022-06-30 — — US disclosed
US-11242339-B2 Chemical inhibition of the E3 ligase subunit FBXO7 confers neuroprotection and anti-inflammatory activity by stabilizing mitochondria University of Pittsburgh—of the Commonwealth System of Higher Education (US) 2022-02-08 — — US disclosed
US-20200216426-A1 CHEMICAL INHIBITION OF THE E3 LIGASE SUBUNIT FBXO7 CONFERS NEUROPROTECTION AND ANTI-INFLAMMATORY ACTIVITY BY STABILIZING MITOCHONDRIA UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2020-07-09 — — US disclosed
WO-2019005685-A1 CHEMICAL INHIBITION OF THE E3 LIGASE SUBUNIT FBX07 CONFERS NEUROPROTECTION AND ANTI-INFLAMMATORY ACTIVITY BY STABILIZING MITOCHONDRIA UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2019-01-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200216426-A1 CHEMICAL INHIBITION OF THE E3 LIGASE SUBUNIT FBXO7 CONFERS NEUROPROTECTION AND ANTI-INFLAMMATORY ACTIVITY BY STABILIZING MITOCHONDRIA FBXL19, MAVS, XIAP SMN1; SMN2 318/4885LMNA 3236/4885ALDH1A1 1963/4885
US-20220204484-A1 CHEMICAL INHIBITION OF THE E3 LIGASE SUBUNIT FBXO7 CONFERS NEUROPROTECTION AND ANTI-INFLAMMATORY ACTIVITY BY STABILIZING MITOCHONDRIA FBXL19, MAVS, XIAP SMN1; SMN2 318/4885LMNA 3236/4885ALDH1A1 1963/4885
US-11242339-B2 Chemical inhibition of the E3 ligase subunit FBXO7 confers neuroprotection and anti-inflammatory activity by stabilizing mitochondria FBXL19, MAVS, XIAP SMN1; SMN2 318/4885LMNA 3236/4885ALDH1A1 1963/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback